Loading organizations...
Key people at 20/20 HealthCare Partners.
20/20 HealthCare Partners operates as a global investment group, focusing on early-stage technology and life science innovation within healthcare. The firm provides critical capital and strategic guidance to emerging ventures, fostering solutions for significant industry challenges. Their approach prioritizes identifying and nurturing companies with high potential for disruptive impact.
Hillel Bachrach, as Managing Partner, and Len Singer, the Financial & Structuring Director, are key figures at 20/20 HealthCare Partners. The firm was founded on the insight that substantial healthcare advancements arise from nascent technologies and scientific breakthroughs, necessitating dedicated early-stage investment. This core belief informs their strategic engagement with portfolio companies.
The group supports visionary entrepreneurs, scientists, and business leaders building transformational companies. 20/20 HealthCare Partners’ vision is to significantly impact and advance healthcare by investing in these innovative entities. They aim to contribute to a future where cutting-edge solutions improve patient outcomes and reshape the sector.
Key people at 20/20 HealthCare Partners.
20/20 HealthCare Partners has 3 tracked investments across 2 companies. The latest tracked deal is $41.5M Series C in Variantyx in February 2022.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 14, 2022 | Variantyx | $41.5M Series C | Gideon Argov | Peregrine Ventures, Pitango HealthTech, Robert Bosch Venture Capital |
| Mar 15, 2021 | Variantyx | $20.0M Series C | Zafrira Avnur | IBM Ventures, NEW ERA Capital Partners, Pitango Venture Capital |
| Jun 1, 2015 | SQZ Biotech | $5.0M Series A | AMY Schulman | ARCH Venture Partners, Flagship Ventures, NanoDimension, Polaris Partners |